Skip to main content
ImmuneCited
Figure 4. The effect of all-trans astaxanthin concentrations on cell viability in group (A) and in group (B) treated with Aβ25–35. : Control group; : astaxanthin-treatment group;
Figure 9. Figure 4. The effect of all-trans astaxanthin concentrations on cell viability in group (A) and in group (B) treated with Aβ25–35. : Control group; : astaxanthin-treatment group;

Deskripsi

The effect of all-trans astaxanthin concentrations on cell viability in group (A) and in group (B) treated with Aβ25–35. : Control group; : astaxanthin-treatment group;

Cite This Figure

![Figure 9: The effect of all-trans astaxanthin concentrations on cell viability in group (A) and in group (B) treated with Aβ25–35. : Control group; : astaxanthin-treatment group;](https://pdfs.citedhealth.com/figures/35447920/123.png)

> Source: Xin Wang et al. "Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase." *Marine drugs*, 2022. PMID: [35447920](https://pubmed.ncbi.nlm.nih.gov/35447920/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/35447920/123.png" alt="The effect of all-trans astaxanthin concentrations on cell viability in group (A) and in group (B) treated with Aβ25–35. : Control group; : astaxanthin-treatment group;" />
  <figcaption>Figure 9. The effect of all-trans astaxanthin concentrations on cell viability in group (A) and in group (B) treated with Aβ25–35. : Control group; : astaxanthin-treatment group;<br>  Source: Xin Wang et al. "Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase." <em>Marine drugs</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35447920/">35447920</a></figcaption>
</figure>